p19Arf inhibits aggressive progression of H-ras-driven hepatocellular carcinoma.

Arf, a well-established tumor suppressor, is either mutated or downregulated in a wide array of cancers. However, its role in hepatocellular carcinoma (HCC) progression is controversial. Conflicting observations have been published regarding its expression in HCC.